BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 21, 2026
Home
»
Topics
»
Disease categories and therapies
» Substance use and poisoning
Substance use and poisoning
RSS
Catalyst Pharmaceutical reports results from phase IIb CPP-109 trial
Nov. 9, 2012
ADX-71441 shows promise in preclinical model of alcohol binge drinking
Oct. 30, 2012
DepoVax found to enhance effect of investigational cocaine vaccine
Oct. 26, 2012
Nabi Biopharmaceuticals reports results from phase II NicVAX vaccine study
Oct. 18, 2012
Reckitt Benckiser to discontinue supply of Suboxone tablets in U.S.
Sep. 28, 2012
University of Pittsburg presents new radioprotectants
Sep. 17, 2012
Pivotal pharmacokinetic study of BEMA-buprenorphine/naloxone meets objectives
Sep. 14, 2012
Orexo submits NDA for sublingual buprenorphine/naloxone product
Sep. 7, 2012
New funding supports Cellerant's development of CLT-008
Sep. 5, 2012
NIDA to fund phase II methamphetamine addiction trial of MN-166
Sep. 5, 2012
Previous
1
2
…
43
44
45
46
47
48
49
50
51
…
119
120
Next